Skip to main content
Sinocare Inc. logo

Sinocare Inc. — Investor Relations & Filings

Ticker · 300298 ISIN · CNE100001CJ0 LEI · 3003008DEKI00A51LU77 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,250 across all filing types
Latest filing 2019-08-15 Transaction in Own Shar…
Country CN China
Listing Shenzhen Stock Exchange 300298

About Sinocare Inc.

https://www.sinocare.com

Sinocare Inc. specializes in the research, development, and manufacturing of biosensor technology and rapid testing products for chronic disease management. The company is primarily recognized for its blood glucose monitoring systems, including meters and test strips, which serve a global patient base. Its product portfolio extends to point-of-care testing (POCT) solutions for HbA1c, uric acid, blood lipids, and other metabolic indicators. Through the integration of advanced sensing technologies and digital health platforms, Sinocare provides comprehensive diagnostic tools for diabetes and related metabolic disorders. The company focuses on delivering affordable and accurate monitoring solutions to improve the quality of life for individuals with chronic conditions worldwide.

Recent filings

Filing Released Lang Actions
回购报告书
Transaction in Own Shares Classification · 95% confidence The document is a detailed announcement from a company about its plan to repurchase its own shares using its own funds. It includes specifics about the purpose of the repurchase, the amount of funds to be used, the price limits, the number of shares to be repurchased, the impact on share capital structure, the authorization by the board, risk disclosures, and compliance with regulatory requirements. The document is titled as a "回购报告书" which translates to "Repurchase Report" or "Buyback Report." It is not a financial report like an annual or interim report, nor is it a regulatory filing or a simple announcement of a report. It is a comprehensive disclosure about a share buyback program. According to the filing definitions, this fits best under "Transaction in Own Shares (POS)" which covers reports of the company buying back or selling its own shares (share repurchase/issuance). The document length is over 10,000 characters and contains substantive details about the buyback plan, so it is not a mere announcement or a short notice. Therefore, the correct classification is POS with high confidence.
2019-08-15 Chinese
独立董事关于第三届董事会第三十八次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent director's opinion on matters discussed at the company's 38th board meeting of the third session, held on August 15, 2019. It references regulatory guidelines from the China Securities Regulatory Commission and Shenzhen Stock Exchange, discusses related party transactions, external guarantees, accounting policy changes, and the use of raised funds for the first half of 2019. The document is a formal opinion letter by independent directors rather than a full financial report or audit report. It does not contain comprehensive financial statements or detailed financial analysis but provides an independent opinion on specific governance and financial matters discussed at a board meeting. This fits the category of Board/Management Information (MANG), which includes announcements related to board activities and management opinions.
2019-08-15 Chinese
第三届监事会第三十一次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of the company SanNuo Biological Sensor Co., Ltd. It discusses the approval of the company's 2019 semi-annual report and related matters, including changes in accounting policies and the use of raised funds. The document states that the full semi-annual report and related announcements are published on the official disclosure website, indicating this document itself is not the full report but an announcement of the resolutions and approvals related to the semi-annual report. The document length is short (1485 characters) and it references the actual report being available elsewhere, fitting the pattern of a Regulatory Filing (RNS) rather than the full Interim/Quarterly Report (IR).
2019-08-15 Chinese
2019年半年度报告披露提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (578 characters) indicating that the company's 2019 semi-annual report (half-year report) has been disclosed on the official disclosure website. It states the report was approved by the board and is available for investors to review. The document itself does not contain the actual financial data or detailed report content but serves as a notice of the report's publication. According to the 'MENU VS MEAL' rule, such a brief announcement about the report's availability is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2019-08-15 Chinese
2019年上半年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2019年上半年度募集资金存放与使用情况的专项报告" which translates to "2019 First Half Year Special Report on the Storage and Use of Raised Funds." It details the amount of funds raised, their usage, storage, management, and compliance with regulatory requirements. The document includes specific financial figures related to fundraising, usage, and balances as of June 30, 2019. It also references regulatory approvals and audit reports related to fundraising activities. The content focuses on the management and use of capital raised through share issuance, which aligns with updates on company fundraising and capital structure changes. The document is comprehensive and contains substantive financial data about fundraising activities for a half-year period but is not a full interim financial report or annual report. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2019-08-15 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the company SanNuo Biological Sensor Co., Ltd. regarding a change in accounting policies. It references a meeting of the board of directors and supervisory board where the change was approved, and it explains the reasons for the change, the impact on financial statements, and includes opinions from independent directors and the supervisory board. The document is relatively short (2651 characters) and does not contain actual financial statements or detailed financial data. It is an announcement about a change in accounting policy rather than a full financial report or audit report. Therefore, it does not fit categories like Annual Report (10-K), Interim Report (IR), or Audit Report (AR). It is also not a regulatory certification or officer attestation. The document is best classified as a Regulatory Filing (RNS) because it is a formal regulatory announcement about accounting policy changes that does not fit other specific categories.
2019-08-15 Chinese

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.